|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001792,
umls-concept:C0029921,
umls-concept:C0036043,
umls-concept:C0040160,
umls-concept:C0086418,
umls-concept:C0087111,
umls-concept:C0178602,
umls-concept:C0205251,
umls-concept:C0271761,
umls-concept:C0439228,
umls-concept:C1522673,
umls-concept:C1707491
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-1-10
|
|
pubmed:abstractText |
The aim of this study was to evaluate the efficacy of recombinant human TSH (rhTSH) as an adjuvant to radioiodine therapy for nontoxic multinodular goiter (MNG) in elderly subjects.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0391-1977
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
191-209
|
|
pubmed:meshHeading |
pubmed-meshheading:17213787-Aged,
pubmed-meshheading:17213787-Case-Control Studies,
pubmed-meshheading:17213787-Combined Modality Therapy,
pubmed-meshheading:17213787-Drug Administration Schedule,
pubmed-meshheading:17213787-Female,
pubmed-meshheading:17213787-Follow-Up Studies,
pubmed-meshheading:17213787-Goiter, Nodular,
pubmed-meshheading:17213787-Humans,
pubmed-meshheading:17213787-Iodine Radioisotopes,
pubmed-meshheading:17213787-Male,
pubmed-meshheading:17213787-Recombinant Proteins,
pubmed-meshheading:17213787-Retrospective Studies,
pubmed-meshheading:17213787-Thyroid Gland,
pubmed-meshheading:17213787-Thyrotropin,
pubmed-meshheading:17213787-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Safety and efficacy of administering 0.2 mg of recombinant human TSH for two consecutive days as an adjuvant to therapy with low radioiodine doses in elderly out-patients with large nontoxic multinodular goiter.
|
|
pubmed:affiliation |
Department of Endocrine and Metabolic Sciences, University of Genoa, Genoa, Italy. magius@unige.it
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
